Historical record - last NADAC effective date: 8/23/2023
Product Information
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0813 per ML under NDC 43386016801. Its NADAC has been published 233 times since Mar 13, 2019.
FDA first approved this application on Aug 29, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 meq/15mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386016801
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209786FDA Approved
8/29/2018
TE Code
AA
On Market Since
9/24/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has been published 233 times since Mar 13, 2019, and over the history we have for it it has declined 78.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0813 per ML |
|---|---|
| All-time high | $0.3794 (Mar 13, 2019) |
| All-time low | $0.0658 (Jan 18, 2023) |
| Median price | $0.2042 |
| Average price | $0.1937 |
| Largest weekly change | +38.2% (Feb 22, 2023) |
| Weeks tracked | 233 |
| Tracking since | Mar 13, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-60.2%
All
-78.6%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
POTASSIUM CHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID, manufactured by Lupin Pharmaceuticals Inc., is $0.0813 per ML (NDC 43386016801), effective Aug 23, 2023.
How has the price of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has declined 78.6%. It has been tracked across 233 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
Since Mar 13, 2019, the NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0658 (Jan 18, 2023) to a high of $0.3794 (Mar 13, 2019), with a median of $0.2042 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID, is $0.0408 per ML — about 50% below POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID.
Who manufactures POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID (NDC 43386016801) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.